Industries > Pharma > Global Chronic Kidney Disease (CKD) Drugs Market Forecast 2018-2028

Global Chronic Kidney Disease (CKD) Drugs Market Forecast 2018-2028

ACE inhibitors, angiotensin-II receptor blockers, calcium channel blockers, beta blockers, erythropoiesis-stimulating agents (ESAs), diuretic, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

PUBLISHED: 05 December 2017
PAGES: 171
PRODUCT CODE: PHA0265
SUBMARKET: Therapeutic Drugs

Clear
WOOCS 2.2.1
SKU: PHA0265 Categories: ,

The Global Chronic Kidney Disease (CKD) Drugs market reached $12.2bn in 2016 and is expected to grow at a CAGR of 3.9% in the first half of the forecast period. The market is dominated by calcium channel blockers and ACE inhibitors.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 171-page report you will receive 85 tables and 93 figures – all unavailable elsewhere.

The 171-page report provides clear detailed insight into the Global Chronic Kidney Disease (CKD) Drugs market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Global Chronic Kidney Disease (CKD) Drugs market forecasts from 2018-2028

• This report also breaks down the revenue forecast for the Global Chronic Kidney Disease (CKD) Drugs market by drug class:
– ACE inhibitors
– Angiotensin-II receptor blockers
– Calcium channel blockers
– Beta blockers: BREVIBLOC, Bystolic
– Erythropoiesis-stimulating agents (ESAs)
– Diuretics
– Others

This report provides a SWOT Analysis for each drug class.

• This report provides revenue forecast for these leading drugs:
– Aceon
– Lisinopril
– Losartan
– AVAPRO
– Twynsta
– BREVIBLOC
– Bystolic
– Mircera
– Epoetin Alfa BS
– Natrilix SR
– Spironolactone
– Urief
– AURYXIA

• This report also breaks down the revenue forecast for the Global Chronic Kidney Disease (CKD) Drugs market by distribution channel:
– Retail Pharmacies
– Hospital Pharmacies
– Online Pharmacies
– Others

• This report also breaks down the revenue forecast for the Global Chronic Kidney Disease (CKD) Drugs market by regional and national market:
– North America: US and Canada
– Europe: Germany, the UK, France, Spain, Italy, Rest of Europe
– Asia-Pacific: Japan, China, India, Rest of Asia-Pacific
– Latin America: Brazil, Mexico, Rest of Latin America
– Middle East & Africa: Saudi Arabia, South of Africa, Rest of MEA

Global Chronic Kidney Disease (CKD) Drugs Market Forecast 2018-2028

Each regional market is further broken down by drug class and distribution channel.

• This report provides company overview, financial information, product portfolio and recent developments for the leading companies in the Global Chronic Kidney Disease (CKD) Drugs market:
– Pfizer, Inc.
– Amgen
– Roche
– GlaxoSmithKline (GSK)
– Allergan
– AbbVie
– Kissei Pharmaceutical Co., Ltd.

Buy our report today Global Chronic Kidney Disease (CKD) Drugs Market Forecast 2018-2028: ACE inhibitors, angiotensin-II receptor blockers, calcium channel blockers, beta blockers, erythropoiesis-stimulating agents (ESAs), diuretic, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Chronic Kidney Disease (CKD) Drugs Market Forecast 2018-2028


Download sample pages

Complete the form below to download your free sample pages for Global Chronic Kidney Disease (CKD) Drugs Market Forecast 2018-2028


Latest Pharma news

Visiongain Publishes Food for Special Medical Purpose (FSMP) Market Report 2020-2030

The food for special medical purpose (FSMP) market growth can be attributed to the growing prevalence of metabolic diseases, growing consumer unhealthy lifestyle, and surge in demand from emerging economies such as Asia Pacific, Middle East & Africa, Latin America, and others.

12 April 2021

READ

Visiongain Publishes Cell-Based Assays Market Report to 2030

Growing incidence of chronic diseases; increasing R&D investment for drug discovery research and Growing Adoption of High-Throughput Screening Methodologies are some of the major factors that propel the market growth.

09 April 2021

READ

Visiongain Publishes Cancer Biologics Therapies Market Report 2021-2031

The main drivers for the growth include technological advancements in the development of novel biomarkers, rising preference for minimally or less invasive surgeries, increasing cancer awareness leading to growth in cancer cases, and growing disposable income in emerging economies.

06 April 2021

READ

Visiongain Publishes Artificial Intelligence (AI) in Drug Discovery Market Report 2021-2031

Factors such as increasing data volumes for analysis, quick turnaround time for the discovery and development new drug, computing power, AI also helps in targeted manufacturing and others drive the market growth.

01 April 2021

READ

Categories